Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects

This phase 1, 2‐part, 2‐period, open‐label, drug‐drug interaction study evaluated the potential for pharmacokinetic interactions between upadacitinib and rosuvastatin, an organic anion transporting polypeptide (OATP) 1B1 and breast cancer resistance protein substrate, or atorvastatin, a cytochrome P...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Mohamed‐Eslam F., Coppola, Sheryl, Feng, Tian, Camp, Heidi S., Kim, Elaine, Othman, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596765/
https://www.ncbi.nlm.nih.gov/pubmed/34109764
http://dx.doi.org/10.1002/cpdd.957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596765/
https://www.ncbi.nlm.nih.gov/pubmed/34109764
http://dx.doi.org/10.1002/cpdd.957

Ejemplares similares